teva to buy cephalon for $6.8 billion, tops valeant
teva pharmaceutical industries ltd   struck a deal to acquire u.s. specialty drugmaker cephalon inc  for nearly $7 billion, topping an unsolicited bid by canada's valeant pharmaceuticals international inc.
http://feeds.reuters.com/~r/reuters/businessnews/~3/vwbqmxeh-sa/us-teva-cephalon-idustre74133720110502
23606
02 May 2011 19:59:19
reuters
business